Free shipping on all orders over $ 500

Recombinant Human MIP-1α/CCL3 (E. coli)

Cat. No. M15024

All AbMole products are for research use only, cannot be used for human consumption.

Recombinant Human MIP-1α/CCL3 (E. coli) Structure
Synonym:

Macrophage Inflammatory Protein-1α; CCL-3; LD78α; LD78 alpha

Size Price Availability Quantity
10ug USD 188 In stock
50ug USD 588 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
  • Purity: >95%, Endotoxin < 1 EU/μg
  • COA
  • MSDS
Biological Activity

Mip-1α polymorphism is associated with HIV susceptibility or drug resistance. Recombinant MIP-1α induces dose-dependent suppression of HIV and SIV infection. In response to endogenous and exogenous factors such as interleukin-1 β, interferon -γ, and gram-positive bacterial lipoteichoic acid, monocytes can secrete large amounts of MIP-1α. Mip-1α enhances the adhesion of T lymphocytes, monocytes, and neutrophils to vascular cell adhesion molecule 1. In addition, miP-1α accelerates tissue repair by chemically attracting macrophages during trauma.

Recombinant Human MIP-1α/CCL3 expressed the target gene encoding Ser24-Ala92.

ED50 < 100.0 ng/ mL, calcium flux was measured using CHO/Gα15 cells expressing CCR5.


Accession: P10147

Endotoxin < 1 EU/µg

Apparent Molecular Weight: 12 KDa, reducing conditions

Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Chemical Information
Form Lyophilized powder
Solubility (25°C) Reconstitute the lyophilized powder in distilled water to a concentration not less than 100 μg/mL.
Storage Stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days and at -20°C for 3 months.
References

[1] Masanori Baba, et al. Antimicrob Agents Chemother. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans

[2] Babatunde O Oyajobi, et al. Blood. Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease

[3] Masahiro Abe, et al. Blood. Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma

[4] C Blanpain, et al. Blood. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist

[5] M Samson, et al. J Biol Chem. The second extracellular loop of CCR5 is the major determinant of ligand specificity

Related Cytokines and Growth Factors Products
Recombinant Human HGF (CHO-expressed)

Recombinant human Hepatocyte Growth Factor (rhHGF) , also known as hepatopoietin-A and scatter factor, is a pleiotropic mitogen belonging to the peptidase S1 family (plasminogen subfamily). It is produced by mesenchymal cells and acts on epithelial cells, endothelial cells and haemopoietic progenitor cells.

Recombinant Human RIPK3 Protein (E. coli, N-His)

RIPK3 is a kinase that controls necroptosis and apoptosis. In necroptosis, activated by TNF-α and ZBP1, RIPK3 phosphorylates MLKL, leading to membrane damage. Necroptosis is dependent on receptor-interacting protein kinase 3 (RIPK3), a protein shown to play an important role in experimental models of critical illness. RIPK3 promotes kidney tubular injury via mitochondrial dysfunction. The FAO-dependent RIPK3 mediates pathogenesis of acute lung injury.

Recombinant Influenza B Hemagglutinin/HA Protein (HEK293, C-His)

Recombinant Influenza B Hemagglutinin / HA Protein is a homotrimer that recognizes target cells in vertebrates and does so by binding to salivary acid-containing receptors on these cells. When it binds to the target cell, it causes the host inner membrane to fuse with the viral membrane, thereby facilitating the entry of the viral genome into the target cell.

Recombinant Human FGF-9 (E. coli)

Fibroblast Growth Factor-9 (FGF-9) is a heparin binding growth factor that belongs to the fibroblast growth factor (FGF) family. ED50 < 2.0 ng/ mL, determined by 3T3 cell proliferation assay, corresponding to > 5.0× 105 units/mg.

Recombinant Human CXCL13/BCA-1 (E. coli)

CXCL13, also known as B-lymphocyte chemoattractant (BLC), is a CXC chemokine that is constitutively expressed in secondary lymphoid organs. Recombinant human CXCL13 is a single non-glycosylated polypeptide chain containing 87 amino acids and mature human BCA-1 shares 64 % amino acid sequence similarity with the murine protein and 23–34 % amino acid sequence identity with other known CXC chemokines. Determined by a chemotaxis bioassay using human B cells, the biological activity is in a concentration range of 1.0-10 ng/ml.

  Catalog
Abmole Inhibitor Catalog




Keywords: Recombinant Human MIP-1α/CCL3 (E. coli), Macrophage Inflammatory Protein-1α; CCL-3; LD78α; LD78 alpha supplier, Cytokines and Growth Factors, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.